# A worry-tracking app reduced worry, not every GAD symptom

> In a 117-person randomized trial, ten days of comparing feared outcomes with reality reduced worry more than thought recording, but it was a short component study, not a replacement for treatment.

_Source: Peer-reviewed randomized controlled trial; verified against PubMed, Europe PMC full text and Crossref · 2026-09-21 · 6 min read · Verified against primary sources_

Canonical: https://iyu.app/e/worry-outcome-monitoring-gad-rct

## The 60-second version

A ten-day worry outcome monitoring exercise reduced worry more than active thought recording, but did not clearly outperform it on overall GAD symptoms.

**Key points**

- The randomized trial included 117 treatment-seeking adults with diagnosed GAD.
- Participants compared concrete feared outcomes with what actually happened.
- Worry and related beliefs improved more in the monitoring group.
- Follow-up was only twenty days and the sample was young and selected.
- The exercise is a possible CBT component, not a substitute for comprehensive care.

**Verdict.** Promising short-term evidence for one structured technique, with no basis yet for calling it a stand-alone treatment or durable app solution.

## Full explainer

> **⚑ Caveat:** The trial found a larger reduction in worry, but not a clear group advantage on the broader GAD symptom measure. It tested a ten-day treatment component, not a complete therapy programme.


### Result — What the randomized trial tested

Researchers randomly assigned 117 treatment-seeking adults with diagnosed generalized anxiety disorder to ten days of worry outcome monitoring or an active thought-recording control. Both used a smartphone four times daily and again each evening.

- **117** — randomized participants
- **10 days** — intervention period
- **20 days** — post-treatment follow-up

The monitoring exercise required a concrete worry, predicted likelihood, actual outcome and coping rating. The control recorded thoughts but did not compare predictions with outcomes.


### Findings — Worry improved more than in the control

- **Primary outcome:** Worry declined more in the monitoring group.
- **Related processes:** Positive beliefs about worry and contrast avoidance also declined more.
- **Broader GAD symptoms:** Both groups improved; the monitoring group did not have a significant group advantage.
- **Feared outcomes:** 89.14% did not occur; when they did, monitoring participants reported coping better than expected 84.35% of the time.

> **i** The 89.14% figure describes worries recorded by this selected study sample. It is not a general probability that applies to every person or every risk.


### Limits — Why this is not an app prescription

- **Short duration:** treatment lasted ten days and follow-up only twenty days.
- **Selected sample:** most participants were young, 80 came from a university pool, and diversity was limited.
- **Research support:** staff supplied individualized daily summaries, unlike most consumer apps.
- **Narrow target:** the exercise isolated one CBT component and did not replace a full treatment plan.

Participants receiving concurrent mental-health treatment or psychotropic medication were excluded. The results therefore do not show how this tool performs alongside ordinary clinical care or in people with more complex needs.


### Interpretation — A useful ingredient, not a cure

> The exercise tests a prediction; it does not diagnose, monitor risk or replace a clinician.

The study supports worry outcome monitoring as a promising technique for making feared predictions testable. Persistent anxiety, major impairment or urgent mental-health symptoms still require qualified assessment and appropriate treatment.


## Primary sources

- [Telegram post 1494](https://t.me/CNSmydream/1494)
- [Journal of Anxiety Disorders paper](https://doi.org/10.1016/j.janxdis.2026.103160)
- [PubMed record](https://pubmed.ncbi.nlm.nih.gov/41946300/)
- [Europe PMC full text](https://europepmc.org/articles/PMC13160596)

---
_Published by iyu (https://iyu.app) — the day's AI news, checked against primary sources and rewritten in plain language. Free to quote with attribution and a link to the canonical URL._